跳至主要内容
临床试验/EUCTR2013-002492-17-AT
EUCTR2013-002492-17-AT进行中(未招募)1 期

Treatment of adenovirus and cytomegalovirus infection post human allogeneic stem cell transplantation with short-term expanded virus-specific T cells - VIsIT

St. Anna Kinderkrebsforschung0 个研究点目标入组 30 人开始时间: 2016年3月3日最近更新:
适应症

试验速览

阶段
1 期
状态
进行中(未招募)
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

入选标准

  • Children and adolescents (0-18 years) who undergo any type of allogeneic stem cell transplantation at the St Anna Children`s Hospital, Vienna.
  • Informed consent is signed
  • Presence of HAdV or CMV-specific T-cells in the donor or CMV-specific T-cells in the recipient pre-transplant
  • Stable (= 10E6) or increasing viraemia despite antiviral treatment post HSCT
  • Absence of virus-specific T cells post transplant
  • Karnofsky / Lansky score >50%
  • Pregnancy excluded
  • Are the trial subjects under 18? yes
  • Number of subjects for this age range: 30
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 2
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Infusion of polyclonal or monoclonal T-cell directed antibodies within 28 days before seVirus T-Cell infusion
  • Multiple organ failure at screening-timepoint seVirus T-Cell infusion
  • History of GvHD Gr III-IV or actual GvHD Gr III-IV
  • Treatment with granulocyte transfusion within the last 72 hours
  • Karnofsky / Lansky score <50%
  • Subject is unwilling or unable to comply with the study procedures
  • High dose treatment with steroids (= 2mg/kg/d, methylprednisone-equivalent)

研究者

相似试验

撤回
1 期
Virus-specific ImmunoTherapy Following Allogeneic Stem Cell TransplantationAdenovirus InfectionCytomegalovirus Infection
NCT02702427St. Anna Kinderkrebsforschung
招募中
3 期
Empirical treatment against cytomegalovirus and tuberculosis in HIV-infected infants with severe pneumonia: a multicenter, open-label randomized controlled clinical trialHIV/AIDSCytomegalovirus pneumoniaRespiratoryPaediatricsTuberculosis
PACTR201904797961340Servicio Madrileno de Salud Fundacion para la Investigacion Biomedica Hospital Universitario 12 de Octubre624
已完成
1 期
Multi-virus (Cytomegalovirus, EB virus, Adenovirus, BK virus, and HHV-6) specific Cytotoxic T-Lymphocytes from HLA-haploidentical or more HLA-matched relative donor to persistent viral infection after hematopoietic cell transplantation (multi-center, prospective phase I/II study)Persistent viral infection after Hematopoietic cell transplanation
JPRN-UMIN000024634Medical Hospital, Tokyo Medical and Dental University3
进行中(未招募)
1 期
Prevention of congenital cytomegalovirus infection in infants of mothers with primary cytomegalovirus infection during pregnancy. A randomised, open, controlled, multicentre and multinational study investigating efficacy and safety of Cytotect FH, nanometer filtered (BT094)Congenital CMV infection after primary CMV infection during pregnancyMedDRA version: 18.0Level: LLTClassification code 10010420Term: Congenital CMV infectionSystem Organ Class: 100000004850
EUCTR2007-004692-19-DEBiotest AG16,000
进行中(未招募)
1 期
Prevention of congenital CMV infection in infants of mothers with primary CMV infection during pregnancyCONGENITAL CMV INFECTION IN NEWBORN FROM MOTHERS WITH PRIMARY CMV INFECTION DURING PREGNANCYMedDRA version: 14.1Level: SOCClassification code 10010331Term: Congenital, familial and genetic disordersSystem Organ Class: 10010331 - Congenital, familial and genetic disordersMedDRA version: 14.1Level: LLTClassification code 10010420Term: Congenital CMV infectionSystem Organ Class: 10010331 - Congenital, familial and genetic disorders
EUCTR2007-004692-19-ITBIOTEST AG25,000